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Background: Dissociation of the Wnt/-catenin pathway effector Dishevelled from its complex with nucleoredoxin is a
redox-sensitive process, yet the ROS sources remain elusive.
Results:Mitochondrial Ca2 influx stimulates endogenous ROS production and mediates Wnt/-catenin pathway activity.
Conclusion: Ca2-mediated ROS production modulates the signaling efficiency of the Wnt/-catenin pathway.
Significance:Metabolic states influence fundamental and developmental signaling to drive cell differentiation.
Emerging evidence suggests that reactive oxygen species
(ROS) can stimulate theWnt/-catenin pathway in a number of
cellular processes. However, potential sources of endogenous
ROS have not been thoroughly explored. Here, we show that
growth factor depletion in human neural progenitor cells
induces ROS production in mitochondria. Elevated ROS levels
augment activation of Wnt/-catenin signaling that regulates
neural differentiation. We find that growth factor depletion
stimulates the release of Ca2 from the endoplasmic reticulum
stores. Ca2 subsequently accumulates in themitochondria and
triggers ROS production. The inhibition of mitochondrial Ca2
uptake with simultaneous growth factor depletion prevents the
rise in ROS metabolism. Moreover, low ROS levels block the
dissociation of the Wnt effector Dishevelled from nucleore-
doxin. Attenuation of the response amplitudes of pathway effec-
tors delays the onset of the Wnt/-catenin pathway activation
and results in markedly impaired neuronal differentiation. Our
findings reveal Ca2-mediated ROS metabolic cues that fine-
tune the efficiency of cell differentiation by modulating the
extent of the Wnt/-catenin signaling output.
Excessive production of reactive oxygen species (ROS)2 leads
to oxidative stress and cell damage in a number of pathologies
(1). Growing evidence suggests that at low concentrations ROS
act as second messengers in a variety of cellular processes and
drive redox-dependent events (2). Recently, ROS production
has been implicated in the regulation of such signaling path-
ways as ERK1/2 and JNK1/2 during directional cell migration,
Akt in cell proliferation, and Wnt/-catenin in proliferation,
regeneration, and embryonic patterning (3–8).
The involvement of ROS in regulating Wnt signaling was
first proposed by Funato et al. (9, 10). They reported that
Dishevelled (DVL) is kept inactive in the cytoplasm by forming
a complex with nucleoredoxin (NRX), a ubiquitously expressed
member of the thioredoxin antioxidant superfamily. DVL has
so far been identified as an intermediate in all known aspects of
Wnt signaling, and DVL translocation from the cytoplasm to
the plasmamembrane is the critical step in the activation of the
Wnt signal transduction (11). Funato et al. (9, 10) showed that
upon treatment of cells with an exogenous pro-oxidant com-
pound, DVL was released from its complex with NRX, which
leads to the stimulation of the Wnt/-catenin pathway. The
data suggested that the changes in intracellular ROS levels
might positively regulate the Wnt/-catenin pathway by mod-
ulating DVL availability to transduce the Wnt signal. One
source of physiologic ROS can be attributed to the elevated
enzymatic activity of plasma membrane NADPH oxidases (5,
6). However, the role of the major cellular ROS source, mito-
chondrial ROS, in the activation ofWnt/-catenin signal trans-
duction remains incompletely understood.
Upon withdrawal of epidermal and basic fibroblast growth
factors (EGF and bFGF), immortalized human neural progeni-
tor ReNcell VM197 cells (hereafter hNPCs) differentiate within
3 days into neurons and glial cells (Fig. 1A) (12, 13). Expression
analysis of a number of WNT ligands, their relative receptors,
and Wnt target genes showed that Wnt/-catenin signaling
regulates the neuronal cell fate commitment of hNPCs within
24 h of differentiation (14, 15). A detailed spatiotemporal pro-
file of total and phosphorylated protein levels of key compo-
nents of theWnt/-catenin transduction pathway LRP6, DVL2
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(dishevelled segment polarity protein 2), and -catenin
revealed their activation already within the first 4 h of differen-
tiation (15). The tightly regulated temporal component of the
Wnt/-catenin pathway activation in hNPCs prompted us to
investigate potential changes in mitochondrial ROS metabo-
lism immediately after growth factor (GF) depletion. We
sought to explore whether ROS levels increase prior to and
whether they are required for Wnt/-catenin pathway activa-
tion. Moreover, we sought to find what mechanisms might be
triggering ROS metabolism.
Here, we provide evidence that in hNPCs, endogenousmito-
chondrial ROS production is markedly increased as a result of
GF depletion at the onset of neural differentiation and that ROS
production precedes the activation of theWnt/-catenin path-
way. We find that GF depletion stimulates the release of Ca2
from endoplasmic reticulum stores through the inositol 1,4,5-
triphosphate receptor, type 1 (ITPR1). Subsequently, a fraction
of Ca2 flows into the mitochondria via the mitochondrial cal-
cium uniporter (MCU). This increase in mitochondrial Ca2 is
required for elevated ROS production. The inhibition of Ca2
efflux via ITPR1 or Ca2 influx via MCU attenuates the ROS
metabolism and prevents the dissociation of DVL2 from its
inactive pool sequestered by NRX in the cytoplasm. Moreover,
the robust activation of DVL2 is blocked as we observe a signif-
icant decrease in the -catenin nuclear accumulation, attenu-
ated expression of Wnt/-catenin signaling target genes, and
impeded neuronal differentiation. Our data reveal that Ca2-
mediated mitochondrial ROS metabolism is directly involved
in the regulation of early events ofWnt/-catenin transduction
and imply that the cellularmetabolic state has an integral role in
the Wnt/-catenin pathway.
EXPERIMENTAL PROCEDURES
Cell Culture andTreatment—The immortalized humanneu-
ral progenitor cell line ReNcell VM197 (ReNeuron)was derived
from the ventral midbrain of 10-week-old human fetal neural
tissues. Cells proliferate in laminin (R&D Systems) pre-coated
flasks under humanbFGF (Invitrogen) andhumanEGF (Sigma)
stimulation in proliferating medium (DMEM/F-12 medium
with B27 neural cell supplement, L-glutamine, heparin, and
gentamycin) (all Invitrogen) as described previously (13). The
differentiation of subconfluent (70–80%) cell layers is induced
by discarding the proliferatingmedium followed byHanks’ bal-
anced salt solution (Invitrogen) rinsing and replacement with
differentiating medium (i.e. medium without growth factors).
Treatment of cells with 0.5 or 10 M ruthenium red (RuR)
(Sigma) was performed for 3 h as follows: 1 h of pretreatment
with the reagent prior to the induction of differentiation, fol-
lowed by a post-treatment up to the 2nd h of differentiation; to
reverse the drug effect, the drug-containing differentiating
medium was replaced by a drug-free medium after Hanks’ bal-
anced salt solution rinsing. Proliferating cells were also pre-
treated with lithium chloride (LiCl; 20 mM, 1 h) and N-acetyl-
L-cysteine (NAC; 10 mM, 24 h) (both Sigma), followed by
post-treatment up to 24 and 72 h after the induction of differ-
entiation, respectively. Cytotoxicitywas assessed by trypan blue
exclusion assay (Invitrogen) or MTT test (Sigma). Cells seeded
in Petri dishes were trypsinized and stained with trypan blue;
the cell counting was performed in triplicate and each condi-
tion assessed in duplicate. For theMTT assay, cells were seeded
in 96-well plates and incubated for 2 h with 50 g/ml MTT
prior to lysis; absorbance at 550 nm was measured with 8 wells
per experimental conditions for each experiment. Data were
obtained from three independent experiments.
Cell Transfection—Cells were transfected with following
human siRNAs as per the manufacturer’s instructions (GE
Healthcare): SMARTpool Accell mitochondrial calcium
uniporter (MCU), SMARTpool Accell inositol 1,4,5-triphos-
phate receptor, type 1 (ITPR1), and Accell nontargeting pool
(negative control). Briefly, 1 M siRNA was mixed to Accell
siRNA delivery medium (GE Healthcare) supplemented with
EGF, bFGF, and B27 neural cell supplement and incubatedwith
cells for 72 h prior to the induction of differentiation.
Confocal Laser ScanningMicroscopy Equipment and Settings—
Fluorescent images of fixed cells were acquired with LSM 710
NLO (Zeiss) and TCS SP5 and TCS SP8 (Leica) confocal
microscopy systems. Live cell imaging was performed using
TCS SP2 (Leica) and A1 (Nikon) confocal microscopes. Live
cell samples were observed in a 37 °C humidified incubation
chamber supplied with a CO2 enrichment system. Cell shape
and integrity were observed in transmitted light to ensure no
cell death occurred during the experimental time frame. The
parameter settings (detector gain and offset, pinhole size, laser
power, confocal section, zoom factor, line and frame averaging)
were kept constant for all comparative sets of experiments.
With these settings, no photobleaching was detected after sev-
eral repeated measurements on the same microscopic field.
Brightness/contrast adjustments were applied equally to every
pixel in the images (i.e. maximum projections) and for each
comparative set (e.g. proliferation versus differentiation) using
Fiji/ImageJ. Adjustments were performed on individual color
channels before merging images. No change to  settings was
applied. Regions of interest were set individually, i.e. for each
cell of the population in the images, based on cell boundaries to
calculate the mean fluorescence intensities (ratio of the sum of
fluorescence intensity emitted in the regions of interest to the
amount of pixels in the regions of interest). For each image, the
background fluorescence was subtracted, and values were nor-
malized. All data were obtained from at least three independent
experiments. For each time point or treatment, at least 10
images per experiment were recorded. Results are shown as
means S.D. arbitrary units.
Redox Balance and ROS Levels—Live cell imaging of intracel-
lular redox state and mitochondrial ROS metabolism were,
respectively, performed with TCS SP2 and A1 confocal micro-
scopes, using the redox indicator carboxy-H2DCFDA (10 M,
1 h) (16) and MitoTracker red CMXRos (50 nM, 45 min) (17),
respectively. Staining of phospholipids ormicrotubule network
using Nile red (10 M, 10 min) or tubulin TrackerTM Green
(100 nM, 0.5 h) (all Invitrogen) allowed discriminating the cell
boundaries for quantification of the mean fluorescence inten-
sities. Nuclei were stained 10 min with 2 M Hoechst 32258
(Sigma). All stainings were done at 37 °C, 5% CO2, in the dark.
Between each staining three washing steps were achieved with
pre-warmed culture medium. For the short term kinetic exper-
iments (i.e. 1 h time line), proliferating cells were pre-loaded
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with the appropriate dyes and then the differentiation was ini-
tiated by GF removal, and the mean intensities were measured
every 10 min. For the long term measurements (i.e. up to 3 h),
the dyeswere loaded right after the differentiationwas induced,
and measurements were performed every 30 min.
Flow Cytometry—Flow cytometry was performed to deter-
mine intracellular redox state and ROS levels. Cells were
stained with carboxy-H2DCFDA or dihydrorhodamine 123
(1 M, 0.5 h) (Invitrogen), a nonspecific indicator for intracel-
lular ROS (16). Staining was performed in Hanks’ balanced salt
solution complemented with 14 mMHEPES and 0.9% NaCl (all
Carl Roth). Mean fluorescence intensities in a total of 104
events (i.e. cells) were determined in each sample using EPICS
XL-MCL flow cytometer system (Beckman Coulter). An
unstained cell sample was carried along as a control for auto-
fluorescence. Data were analyzed for four independent expo-
sure experiments measured in duplicate. 1–3 mM hydrogen
peroxide (H2O2) (Invitrogen) and 5 M phorbol 12-myristate
13-acetate (Sigma) were used as positive controls.
Ca2 Imaging—Endoplasmic reticulum (ER) and mitochon-
drial Ca2 fluxes weremonitored with A1 confocal microscope
usingmag-fluo-4AM(5M, 0.5 h) (18) and x-rhod-1AM(2M,
0.5 h) (19), respectively. Fura red AM (20 M, 0.5 h) (all Invit-
rogen) was used to assess cytosolic Ca2 levels (20, 21) with a
TCS SP2 confocal microscope. 1–10 mM caffeine (CAF) (Cal-
biochem) was used as positive control. Fura red, although pre-
sented as a ratiometricCa2 indicator through a dual excitation
wavelength mode (440 and 488 nm for Ca2-bound and -un-
bound forms, respectively), is rarely used this way because of
the weak quantum yield of the Ca2-bound form (21). Also,
fura red was used here as a single wavelength emission dye, i.e.
the Ca2-unbound form. An increase of cyto-Ca2 levels leads
to a decrease of the measured fura red intensity due to the
binding of Ca2 (i.e. reduction of the pool of Ca2-unbound
form of the dye). Results were presented as F0/F ratio (F0 and F
corresponding to the mean fluorescence intensities measured
within proliferating cells and differentiating or treated cells,
respectively).
Western Blotting—Protein extraction from the cells was
achieved using Triton lysis buffer supplemented with protease
and phosphatase inhibitor mixtures (Sigma). Cell lysates were
loaded with Laemmli buffer, centrifuged for 10 min, and boiled
for 5 min. Proteins were separated by SDS-PAGE using 10%
SDS-polyacrylamide gel and transferred in awet condition onto
a nitrocellulose membrane (Amersham Biosciences). After
blocking with 5% nonfat dry milk, proteins were labeled over-
night with primary antibodies as follows: goat anti-NRX (R&D
Systems, AF5719; dilution 1:2000); rabbit anti-DVL2 (Cell Sig-
naling, 3216; dilution 1:500); and rabbit anti-GAPDH (Santa
Cruz Biotechnology, sc-25778; dilution 1:800) used as stable
housekeeping protein. Proteins were probed for 1 h with HRP-
conjugated secondary antibodies as follows: anti-goat (Santa
Cruz Biotechnology, sc-2020; dilution 1:50,000) and anti-rabbit
(Sigma, A9169; dilution 1:80,000). Signals were detected with
ECLWestern blot detection reagent (GEHealthcare) andquan-
tified with Fiji/ImageJ. Relative signal intensities were normal-
ized to GAPDH.
Immunocytochemistry—Cells grown on glass coverslips pre-
coated with poly-D-lysine and then with laminin were fixed 20
minwith 4% paraformaldehyde and 4% sucrose in PBS followed
by 10 min of quenching with 50 mM NH4Cl and 5 min of per-
meabilization with 0.2% Triton X-100. Nonspecific binding
sites were blocked for 1 hwith 1% gelatin (all Sigma). Cells were
loaded 1 hwith primary antibodies as follows: rabbit anti-DVL2
(SantaCruz Biotechnology, sc-13974; dilution 1:200); goat anti-
NRX (Santa Cruz Biotechnology, sc-161973; dilution 1:200);
mouse anti--tubulin (Sigma, T5168; dilution 1:1000); mouse
anti--catenin-Alexa488-conjugate (Pharmingen, 562505;
dilution 1:200); mouse anti-glial fibrillary acidic protein-Cy3-
conjugate (Sigma, C9205; dilution 1:400); mouse anti-III-tu-
bulin-FITC-conjugate (Abcam, ab25770; dilution 1:80); and
mouse anti-Hu antigensC andD (Invitrogen, A-21271; dilution
1:300). After rinsing with 0.2% gelatin, secondary antibodies
were loaded during 45min as follows: anti-rabbit or anti-mouse
Alexa488; anti-goat Alexa594; and anti-mouse Alexa647 (all
Invitrogen; dilution 1:500). Nuclei were stained with Hoechst
32258 (2 M, 10 min). A post-fixation step was performed with
2% paraformaldehyde for 10 min to prevent any dissociation of
secondary antibodies, followed by a quenching step with 50mM
NH4Cl for 5 min. Coverslips were mounted using prolong gold
antifade reagent (Invitrogen). Images of DVL2 and NRX were
acquired using a TCS SP8 confocal microscope. Localization of
-catenin or neuronal markers was assessed using LSM 710
NLO confocal system.
FRET Measurement—To assess physical protein-protein
association between DVL2 and NRX, we used FRET micros-
copy (22) through the sensitized emission method using a TCS
SP5 confocal microscope equipped with 63 1.4NA differen-
tial interference contrast oil HCX Plan-Apo objective. The
parameter settings were kept constant throughout all experi-
ments. The donor (Alexa488-labelingDVL2)was excited at 488
nm, and a restrictive detection wavelength range was set at
490–550 nm to avoid leakage of acceptor fluorescence into the
donor image. The acceptor (Alexa594-labeling NRX) was
excited at 594 nm, and the detection range was set at 620–700
nm. The FRET signal was acquired in line-by-line sequential
mode. First the donor and the FRET signal were detected after
the selective excitation of the donor. Then the acceptor was
excited with the selective excitation light, followed by the
detection of the acceptor signal only. This acquisition method
involving suitable laser switching-on avoided the excitation of
the other fluorochrome. We used reference samples (cell spec-
imens labeled with donor only or acceptor only) to supply cal-
ibration coefficients for the correction of excitation and emis-
sion cross-talk (i.e. direct acceptor excitation and donor
emission bleed-through) from the FRET specimen (cell sample
labeled with both donor and acceptor). Following this proce-
dure, the fully corrected FRET image was obtained (according
to the recommendations in Ref. 23). The proportion of direct
protein-protein binding, i.e. FRET efficiency (FRETeff), was cal-
culated using the equation of Van Rheenen et al. (24). FRETeff
was measured inside individual cells (n100 per time point)
for every condition. Measurements were performed for three
independent experiments.
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Quantitative Real Time PCR—Cell disruption and purifica-
tion of total RNAwere performedwith high pure RNA isolation
kit (Roche Applied Science) according to the manufacturer’s
instructions. Residual contaminating genomic DNA was
digested by DNase I recombinant RNase-free (Roche Applied
Science). cDNA synthesis was primed with oligo(dT)18 primers
and generated from 1 g of template RNA with Moloney
murine leukemia virus reverse transcriptase using first strand
cDNA synthesis kit (Thermo Scientific). RT-PCR was per-
formed as follows: 5 min at 25 °C, 60 min at 37 °C, and 5 min at
70 °C. Real time PCR quantitation was performed by mixing
100 ng of template cDNAwithTaqMan gene expressionmaster
mix and following TaqMan gene expression assays (all Applied
Biosystems): MCU (Hs00293548_m1); ITPR1 (Hs00181881_
m1); AXIN2 (Hs00610344_m1); MAP2 (microtubule-associ-
ated protein 2; Hs00258900_m1); RPL13A (ribosomal protein
L13a; Hs04194366_g1). Contents were transferred into 96-well
PCR plates (Thermo Scientific) with a final concentration of
cDNA of 5 ng/l in each well. Amplifications were performed
using iQ5 real time PCR detection system (Bio-Rad) as follows:
2 min at 50 °C for activation of the uracil-N-glycosylase; 10min
at 95 °C for polymerase activation; 40 repeats of two-step
cycling (15 s at 95 °C for denaturation and 1 min at 60 °C for
annealing and extension). Relative expression values were
obtained by normalizing Ct values of the tested genes in com-
parison with Ct values of ribosomal protein L13a (RPL13A,
housekeeping gene) using theCtmethod (25). Each condition
was assessed from three independent samples in duplicate.
Results are presented as fold induction means  S.D. from
three independent experiments.
Statistical Analysis—Statistical analyses were performed
using two-tailed unpaired Student’s t test. *, p  0.05, signifi-
cantly different from the control (untreated proliferating cells).
Data are presented as means S.D. and averaged from at least
three independent experiments.
RESULTS
Mitochondrial ROS Metabolism Is Altered during the Early
Differentiation Phase of hNPCs—The onset of neural differen-
tiation in hNPCs is regulated in a narrow time range by the tight
activation of Wnt/-catenin pathway components. Whether
endogenous ROS levels could increase after GF depletion and
play any role in DVL2-NRX dissociation is unclear. To assess
the changes in intracellular ROS levels, we first monitored the
cellular redox balance state using the redox indicator carboxy-
H2DCFDA (16) at 10-min intervals within the 1st h, followed by
0.5-h intervals for 3 h throughout the initial phase of differen-
tiation (Fig. 1, B–D). Proliferating cells showed only a faint sig-
nal (Fig. 1B, 0h, arrows). Upon induction of differentiation, the
signal increased within 30 min (Fig. 1B, 0.5h), reached its max-
imum after 1 h, and returned to baseline after 2.5 h (Fig. 1, B,
2.5h, arrow, C and D). In parallel, we quantified the cellular
redox state using flow cytometry and obtained similar results
(Fig. 1E).
Exchange of cell culture medium can impose oxidative stress
(26); however, sequential exchanges of the proliferating
medium in the dye pre-loaded cells did not cause any increase
in the fluorescent signal showing that neither cell stress nor
redox imbalance occurs during the experimental time frame
(Fig. 1F). The 0.5-h incubation of proliferating cells with pro-
oxidant agent H2O2 (1 mM) resulted in the increased redox
imbalance, as anticipated (Fig. 1, D and E). Although H2O2
cytotoxicity depends on various factors, including the dose or
the incubation time (27), the cytotoxic effect of H2O2 (3 mM)
was noticeable only 2 h after treatment (41%). Consistent with
the reported data (28), no visible and only minor (13%) cyto-
toxic effects were observed after 0.5 and 1 h, respectively (Fig.
1G). Thus, our data attribute the increase in the intracellular
redox imbalance in the first 3 h of hNPCs differentiation solely
to GF depletion.
The changes in the redox state could reflect the rise in ROS
production in the mitochondria. We examined the mitochon-
drial ROS (mito-ROS) metabolism using the MitoTracker red
marker (17). The dye accumulated in mitochondria in a
quenchednonfluorescent state (Fig. 2A, 0h).mito-ROSproduc-
tion led to an increased fluorescence within 0.5 h of differenti-
ation (Fig. 2, A, 0.5h, B and C) and dropped to baseline by 3 h
(Fig. 2, A, 2.5h, and C). Using flow cytometry, we obtained sim-
ilar results with cells stained with another ROS-sensitive dye,
dihydrorhodamine 123 (Fig. 2D) (16). Treatment of proliferat-
ing cells with pro-oxidant agents, H2O2 (1 mM) or phorbol
12-myristate 13-acetate (5 M), induced a significant increase
of the fluorescent signal after 0.5 and 1 h, respectively (Fig. 2, C
and D).
Our data show the dynamic changes in the redox state at the
early phase of hNPC differentiation and reflect the alteration in
the cellular physiology. They further reveal the existence of a
switch in mitochondrial ROS production within 30 min after
GF depletion.
GF Depletion Mediates Early ER-Ca2 Release and mito-
Ca2 Influx—Intracellular Ca2 is a ubiquitous messenger
involved in various aspects of cell physiology (29), e.g. Ca2
influx into the mitochondria stimulates ROS generation (30–
32). EGF and bFGF reportedly inhibit ITPR-dependent Ca2
release from intracellular stores (33, 34). We therefore asked
whether GF depletion could result in changes in intracellular
Ca2 fluxes and affect ROS metabolism. To examine the intra-
cellular Ca2 distribution after GF depletion, we used fluores-
cent dyes that preferentially bind Ca2 in the ER, cytosol, and
mitochondria and monitored the Ca2 fluxes.
The ER-Ca2 can be detected using mag-fluo-4, which
exhibits fluorescent intensity proportional to ER-Ca2 levels
(18). The mag-fluo-4 clearly labeled the ER network in prolif-
erating cells (Fig. 3A, 0h); after 0.5 h of differentiation, the signal
significantly decreased indicating the Ca2 release from the ER
stores (Fig. 3A, 0.5h, arrows). Similarly, a 1-h treatment of pro-
liferating cells with 1 mM CAF, which stimulates Ca2 release
from the ER stores via the ryanodine receptors (35, 36), strongly
decreased the signal (Fig. 3B). Of note, in agreement with
reports showing CAF cytotoxicity only after longer exposures
(37), a 2-hCAF treatment of proliferating cells leads to only 10%
of cell death (Fig. 3C).
Next, we assessed the changes in cytosolic Ca2 (cyto-Ca2)
levels after GF depletion using ratiometric fura red. The dye
fluoresces in its Ca2-unbound form, so an increase in cyto-
Ca2 concentration diminishes the signal (20, 21). Consistent
Ca2-mediated ROS AugmentWnt/-Catenin Signaling
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with the observed ER-Ca2 release, the cyto-Ca2 levels in dif-
ferentiating cells increased within 10 min and reached maxi-
mum by 0.5 h as detected by low levels of the Ca2-unbound
form (Fig. 3, D, 0.5h, and E) and returned to baseline at 3 h of
differentiation (Fig. 3,D, 3h, and E). These data corroborate the
inverse relationship between ER and cytosolic Ca2 levels.
Although intracellular Ca2 levels remained unchanged in pro-
liferating cells after the sequential exchanges of proliferative
medium (Fig. 3F), 1 h of CAF treatment led to an increase in
cyto-Ca2 levels, comparable with the increase at 0.5 h in dif-
ferentiating cells (Fig. 3, E and G).
To assess the mito-Ca2 levels, we used x-rhod-1, a dye that
preferentially accumulates inmitochondria and fluoresces pro-
portionally to the Ca2 levels in these organelles (19). The
mito-Ca2 signal markedly rose after 0.5 h of differentiation
indicating an increasedmitochondrial Ca2 influx (Fig. 4,A, 0h,
FIGURE 1. Induction of differentiation alters intracellular redox balance. A, confocal images of neurons (III-tubulin, green) and glia cells (red) at 0 h
(proliferating cells) and 2 days after initiation of differentiation. Nuclei are shown in blue. Mature neurons were quantified based on III-tubulin labeling.
Immature neurons were quantified through the labeling of the neuronal RNA-binding protein Hu-antigens C and D (HuC/D) that is expressed earlier than
III-tubulin. n9000 cells per time point. B, confocal images of redox state (grayscale; green in merge) at 0, 0.5, and 2.5 h of differentiation. White arrows
indicate faint signal at 0 and2.5h. Phospholipids (red) andcell boundaries (dottedwhite lines) are shown.C, kinetics of the cellular redox statemeasuredasmean
fluorescent intensity at 10-min intervals over the 1st h of differentiation. Significant increase appears at 30minof differentiation.n150 cells per timepoint.
D, kinetics of the cellular redox statemeasured asmean fluorescent intensity at 0.5-h intervals over the first 3 h of differentiation. Redox state reaches baseline
levels after 3 h. n150 cells per time point. E, kinetics of the cellular redox state measured as mean fluorescent intensity at 0.5-h intervals over the first 3 h
of differentiation using flow cytometry. a.u., arbitrary units. F, confocal images of intracellular redox state (grayscale; green in merge) after three sequential
exchanges of proliferatingmedium in pre-stained proliferating cells. Phospholipids are in red. Mean fluorescent intensities show change in redox state only in
differentiating cells. n50 cells per time point. G, cytotoxic effect of 3 mM H2O2 assessed with MTT. *, p 0.05. Error bars, S.D. Scale, 10 m.
Ca2-mediated ROS AugmentWnt/-Catenin Signaling
OCTOBER 3, 2014•VOLUME 289•NUMBER 40 JOURNAL OF BIOLOGICAL CHEMISTRY 27941
 at M
ax-D
elbruck-Centrum
 fur on N
ovem
ber 7, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
0.5h, and B), and decreased by 3 h of differentiation (Fig. 4, A,
3h, and B). CAF treatment of proliferating cells also increased
mito-Ca2 levels (Fig. 4C) corroborating the data observed in
differentiating cells. Altogether, these data indicate that GF
depletion leads to an increased Ca2 efflux from the ER to the
cytosol and a subsequent Ca2 influx into the mitochondria
within the first 30 min of differentiation.
mito-Ca2 Uptake Triggers the ROS Metabolism—The
observed intracellular Ca2 dynamics occur concomitantly
with the changes in mito-ROS metabolism and cellular redox
state (compare Figs. 1, C and D, 2, B and C, 3E, and 4B). RuR
reportedly blocks the mito-Ca2 uptake by inhibiting the
MCU, themain conduit for mitochondrial Ca2 influx (38, 39).
We prevented mito-Ca2 influx by incubating cells with RuR
(see under “Experimental Procedures” for details, Fig. 5A), and
we monitored Ca2 levels within mitochondria for 3 h. The
effect of RuR was dose-dependent; at 0 h, the high dose (10M)
strongly reduced the signal indicating the decrease of baseline
mito-Ca2 levels, whereas the low dose (0.5 M) did not cause
any significant change in comparison with untreated cells (Fig.
5, B–D, 0h). At 1 h, Ca2 accumulated within themitochondria
in untreated cells, whereas 0.5 M RuR prevented mito-Ca2
uptake (Fig. 5, C and D, 1h). At 3 h, the mito-Ca2 levels
dropped to baseline in the untreated cells. Conversely, after 0.5
MRuR removal, mito-Ca2 levels significantly increased indi-
cating that the drug effect is reversible (Fig. 5,C andD, 3h). The
effect of the high dose was long lasting, and the mito-Ca2
levels were decreased for the entire examined period (Fig. 5B).
To assess the functional link between mito-Ca2 and ROS
metabolism at the onset of hNPC differentiation, we examined
the mito-ROS production after inhibiting Ca2 influx into the
mitochondria. At 0 h, mito-ROS levels in 0.5 M RuR-treated
cells were comparable with the untreated cells (Fig. 5, E, 0h, and
F). After 1 h of differentiation, the lowdose prevented the rise in
ROS levels (Fig. 5, E, 1h, and F). However, 1 h after the drug
removal, its effect was reversed, and the mito-ROS production
was elevated (Fig. 5, E, 3h, and F). The high dose drastically
reduced the signal and completely abolished mitochondrial
metabolism, presumably due to its cytotoxicity (Fig. 5,G and
H). The low dose did not cause any significant cell death (Fig.
5H).
These data demonstrate that the effect of short term treatment
with 0.5 M RuR is nonlethal and reversible, and inhibits both
mito-Ca2 uptake andROS increase.Moreover, our findings sug-
gest thatmito-ROSmetabolism is triggered by a rise inmito-Ca2
levels at the onset of differentiation.
Ca2-mediated ROSMetabolism Dissociates the DVL2-NRX
Complex—The GF depletion results in the activation of Wnt/
-catenin pathway that is required for induction of hNPC dif-
ferentiation (14, 15, 40). One way to modulate the Wnt/-
catenin pathway activity is to regulate the availability of DVL2.
The exogenously triggered ROS production leads to the disso-
ciation of DVL from its complex with NRX (9). We therefore
hypothesized that the endogenous changes in ROS levels medi-
ated bymito-Ca2 fluxes can tune the activation of theWnt/-
catenin cascade in hNPCs. First, we verified the reported data
showing the early kinetics of DVL2 activity in these cells (15).
ThroughWestern blotting and immunocytochemistry, we con-
firmed that DVL2 protein levels are elevatedwithin 1 h after GF
depletion, followed by the moderate reduction at 3 h (Fig. 6, A
and B). Markedly, we found that NRX protein levels followed
the same pattern; the NRX accumulated within 1 h, and its
levels decreased by 3 h (Fig. 6, A and B). If the DVL2 and NRX
accumulation were mediated through the increase in intracel-
lular ROS, the treatment of proliferating cells with pro-oxidant
agent would result in higher DVL2 and NRX protein levels.
Conversely, inhibiting the ROS production would prevent the
DVL2 and NRX increase. Indeed, although DVL2 and NRX
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proteins were significantly elevated after 1mMH2O2 treatment
of proliferating cells (Fig. 6A), the incubation of differentiating
cells with 0.5 M RuR delayed the accumulation of both DVL2
and NRX proteins (Fig. 6B, control 1h versus RuR 3h). These
data suggest that preventing mitochondrial ROS formation
affects cytoplasmic DVL2 as well as NRX protein levels.
To address whether the altered redox and metabolic cell
states could mediate the dissociation of DVL2 from NRX, we
examined the physical association between the two proteins by
fluorescence resonance energy transfer (FRET) microscopy for
a period of 3 h after GF removal (23, 24). At 1 h after differen-
tiation, the proportion of DVL2 bound to NRX as measured by
FRET efficiency(FRETeff) significantly decreased (Fig. 7,A, con-
trol, 1h, and B, empty histograms). The H2O2 treatment of pro-
liferating cells also resulted in decreased FRETeff (Fig. 7, A,
H2O2, and B). Markedly, 0.5 M RuR treatment inhibited the
dissociation of DVL2-NRX complexes. FRETeff between DVL2
and NRX was high in RuR-treated cells 1 h after differentiation
(Fig. 7, A, RuR, 1h, and B, full histograms). Drug removal pro-
moted dissociation of DVL2 from NRX as the FRETeff
decreased (Fig. 7, A, RuR, 3h, and B). These data show that the
mito-Ca2-mediated physiologic increase in ROS levels may
facilitate fast dissociation rate of DVL2 from the initial pool of
DVL2-NRXcomplexes.DVL2 andNRXproteins accumulate in
the cytoplasm as a result of their reduced physical interactions.
In the absence of elevated ROS production, DVL2 is kept inac-
tive in the cytoplasm by binding to NRX.
Nuclear Accumulation of -Catenin Is Enhanced by Increase
in Ca2-mediated ROS Metabolism—As a result of Wnt/-
catenin pathway activation, -catenin accumulates in the cyto-
plasmand shuttles to the nucleus (41). In the nucleus,-catenin
binds TCF/LEF1 transcription factors and drives the expres-
sion of specific target genes that control cellular processes rang-
ing from proliferation to cell differentiation (41–43). We rea-
soned that blocking Ca2-mediated ROS metabolism would
decrease the pool of unbound DVL2 and inactivate the trans-
duction cascade. We therefore examined the ability of -
catenin to localize into the nucleus in RuR-treated cells. At 0 h,
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the nuclear -catenin signal was identical between untreated
and RuR-treated cells (Fig. 8A, 0h versus 0hRuR). After 3 h of
differentiation, -catenin accumulated in the nuclei of
untreated cells (Fig. 8A, 3h) confirming previous reports (15). In
contrast, RuR treatment prevented nuclear accumulation of
-catenin in differentiating hNPCs (Fig. 8A, 3hRuR). We
monitored the kinetics of -catenin nuclear localization by
quantifying its mean fluorescence intensities along the first 4 h
of differentiation (Fig. 8B). The nuclear -catenin signal was
significantly enhanced in untreated cells from 2 h of differenti-
ation onward (Fig. 8B, empty histograms). Frequency distribu-
tion analysis revealed that at 3 h of differentiation, two cell
populations emerge as follows: the first one, in which-catenin
levels are comparable with proliferating cells, and the second
one with twice as high mean intensities representing the cells
with the accumulated nuclear -catenin (Fig. 8C, 3h versus 0h).
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RuR treatment prevented the two cell populations to emerge
(Fig. 8C, 0hRuR versus 3hRuR), but a moderate increase in
the nuclear mean intensities of -catenin occurred after
drug removal (Fig. 8B, full histograms, 4h). These data indi-
cate that Ca2-mediated ROS metabolism enhances the
nuclear -catenin accumulation andmay affect the rate of its
nucleo-cytoplasmic shuttling.
Ca2-mediated ROS Metabolism Augments the Wnt/-
Catenin Signaling—To definitively demonstrate that Ca2-me-
diated ROS metabolism modulates the Wnt/-catenin signal-
ing, we genetically perturbed the ER and mitochondrial Ca2
fluxes and examined their effects on Wnt target gene expres-
sion during hNPC differentiation. We reduced ITPR1 (mam-
malian brain predominant isoform (44)) to inhibit Ca2 release
from the ER stores, andMCU to block the Ca2mitochondrial
influx (39). We first assessed the silencing efficiency for both
ITPR1 andMCU; ITPR1 expression was stably reduced by 50%
and MCU by 90% as compared with untransfected cells and
cells transfected with untargeted siRNA (control cells) (Fig.
9A). Next, we examined the functional effects of ITPR1 and
MCU silencing. At 0 h, the ER-Ca2 levels were comparable
between control cells and cells with the reduced ITPR1 (Fig.
9B). At 1 h of differentiation, ER is depleted of Ca2 by 50% in
control cells (compare with Fig. 3A), in contrast loss of ITPR1
FIGURE 6.DVL2andNRXamounts are affectedbyCa2-mediatedROSmetabolism.A,Western blots of DVL2 andNRX showing a ROS-dependent increase
of both protein amounts occurring 1 h after differentiation or after H2O2 treatment (1 mM). All bands are from the same blot. The signal intensities were
normalized to 1 at 0 h (proliferating cells) and quantified as a fold change. B, confocal images of DVL2 (green) and NRX (glow dark) in untreated and 0.5 M
RuR-treated cells at 0, 1, and 3 h of differentiation. RuR inhibits the increase of both proteins (1 h) and removal of RuR allows for the cytosolic accumulation of
bothproteins (3h).Mean fluorescent intensities arequantified inbargraphs.n200cells per timepoint. *,p0.05. Error bars, S.D. Scale,10m;a.u., arbitrary
units.
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completely blocks ER-Ca2 release after GF depletion (Fig. 9B).
Similarly, Ca2 influx into mitochondria is increased after 1 h
of differentiation in control cells (by80%) (compare with Fig.
9C to Figs. 4, A and B, and 5, C and D) but is significantly
suppressed in the absence ofMCU. Of note, the basal levels of
mito-Ca2 are mildly affected in proliferating cells transfected
with MCU siRNA. These changes in Ca2 fluxes have a pro-
found effect onROSmetabolism.Although in control cells ROS
levels significantly increase 1 h after differentiation (see also
Figs. 2,A–C, and 5, E and F), loss of both ITPR1 andMCU affect
the ROSmetabolism already in proliferating cells and diminish
the mito-ROS production after induction of differentiation
(Fig. 9D), indicating that Ca2 flux throughMCU is critical for
cellular bioenergetics as suggested previously (45). The data
show that Ca2 influx into mitochondria triggers mito-ROS
metabolism, corroborating the specificity of RuR.
We then addressed whether Wnt/-catenin signaling is
affected when Ca2-mediated ROS metabolism is perturbed.
We tested the expression levels of twoWnt/-catenin pathway
target genes: AXIN2 and MAP2, a neuron-specific microtu-
bule-associated protein 2 (46, 47). We observed 3-fold increase
in AXIN2 and 4-fold increase inMAP2 expression 2 days after
differentiation in untreated and control cells (Fig. 10A); a sim-
ilar increase inWnt target gene expression was reported previ-
ously (15). In cells treated with 20 mM lithium chloride (LiCl, a
potent Wnt pathway agonist (48)), AXIN2 levels increased by
20-fold (Fig. 10A). In contrast, RuR treatment as well as loss of
ITPR1 and MCU significantly reduced the AXIN2 and MAP2
mRNA levels at this time point (Fig. 10A). Taken together, our
findings demonstrate thatCa2 release from the ER at the onset
of hNPC differentiation depends, at least in part, on ITPR1
activity. Subsequent Ca2 influx into the mitochondria
requires MCU and stimulates ROS production. Moreover,
these data show that reduced Ca2-mediated mitochondrial
ROS metabolism has a negative impact on Wnt target gene
expression.
Ca2-mediated ROS Metabolism Potentiates the Wnt/-
Catenin-dependent Neuronal Differentiation—Our findings
that Ca2-mediated ROS metabolism enhances the Wnt/-
catenin signaling output infer that the neuronal yield of differ-
entiating hNPCs could be modulated by the mitochondrial
Ca2 influx and ROS production. To test the effect of Ca2-
mediated ROS metabolism perturbations on hNPC neural fate
commitment, we quantified the neuronal yield after 3 days of
differentiation in cells with disrupted ROS metabolism. We
treated the cells eitherwith 0.5MRuRor 10mMNAC, a potent
ROS scavenger that protects against oxidative stress (49). Upon
GF removal, 12% of the untreated cells differentiated into neu-
rons (Fig. 10, B and C). Inhibiting mito-Ca2 uptake with RuR
had a profound effect on the neuronal yield. Only 6% of the cells
differentiated into neurons (Fig. 10, B and C). Similarly, NAC
also reduced the neuronal yield to 6% (Fig. 10, B and C). NAC
treatment efficiently blocked the ROS increase at the onset of
hNPC differentiation, indicating its high antioxidant capacity
(Fig. 10D). Conversely, stimulating Wnt/-catenin signaling
with LiCl significantly enhanced the neuronal yield up to 17%,
confirming that the induction of the Wnt/-catenin pathway
promotes the neuronal differentiation in our cell model. Of
note, the proportion of differentiated neurons of the RuR-
treated cells at 3 days was comparable with that observed with
untreated cells at 2 days after GF depletion indicating delayed
and ineffective differentiation (Figs. 1Aversus 10C). Altogether,
we demonstrate that a change inCa2-mediatedmitochondrial
ROS metabolism at the onset of hNPC differentiation is
required for fine-tuning the Wnt/-catenin signaling effi-
ciency, which in turn controls the decision of the cells to com-
mit to their neuronal fate.
DISCUSSION
In our study, we provide direct evidence that an endogenous
increase inmitochondrial ROSmetabolism accelerates the rate
ofDVL2dissociation from its complexwithNRXand augments
Wnt/-catenin signaling efficiency. We further unravel the
mechanisms that regulate ROS production in the initial phase
of neural differentiation in hNPCs. At steady state, GF sup-
presses ER-Ca2 release through ITPR1. UponGF removal, the
inhibition is alleviated and Ca2 floods the cytoplasm. The
increased intracellular Ca2 concentration drives a number of
responses, one of which involves the opening of MCU at the
outer mitochondrial membrane. The increased mitochondrial
Ca2 influx changes the oxidative state of themitochondria and
triggers the endogenous ROS production. Importantly, loss of
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ITPR1 or MCU abolished Ca2 influx into the mitochondria
and subsequent increase in ROS metabolism.
ROS involvement in stimulation of theWnt/-catenin path-
way has been previously described in a number of cellular pro-
cesses, including cell proliferation or regeneration (5–8). An
increase in ROS levels is prerequisite for preventing binding of
DVL2 to NRX, but the sources of ROS production remain
incompletely understood. The changes in ROS levels could be
stimulated by the use of exogenous pro-oxidant compound
such as H2O2, by exogenous insult such as surgical amputation,
or by induction of expression ofNADPHoxidases (5–10). Here,
we demonstrate that physiologically induced mitochondrial
ROS production is necessary to dissociate DVL2-NRX com-
plexes in a time-dependentmanner. Our data further show that
bothDVL2 andNRXproteins accumulate in the cytoplasm and
cease to interact despite their elevated protein levels. Further
studies need to clarify what leads to DVL2 and NRX cytosolic
accumulation or how much of the total DVL pool is in fact
controlled by its interaction with NRX.
The cytosolic-catenin accumulation and translocation into
the nucleus are essential to the activation of theWnt/-catenin
pathway (41–43). GF withdrawal increased the -catenin
nuclear accumulation from 2 h after induction of differentia-
tion (this study and Ref. 15). We find that -catenin nucleo-
cytoplasmic shuttling occurs only after the rise in Ca2-medi-
ated ROS levels and after DVL2-NRX complexes are
dissociated. Remarkably, blocking the Ca2-mediated ROS
metabolism either pharmacologically or genetically suppressed
nuclear -catenin accumulation as well asWnt/-catenin gene
target activation. Moreover, interfering with the Ca2-medi-
ated ROSmetabolism at the onset of differentiation suppressed
the long term neuronal differentiation of hNPCs. Our findings
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demonstrate that Ca2-mediated ROS metabolism modulates
the neural differentiation and requires the release of high levels
of free DVL2. We propose that such an en masse release of
DVL2 ensures a robust andmore efficient activation ofWnt/-
catenin signaling.
The following model summarizes the spatio-temporal
dynamics of the successive events (Fig. 11): while the stimula-
tion of EGF and bFGF retains Ca2 in the ER stores during the
proliferation phase (Fig. 11, left panel), theirwithdrawal leads to
ITPR1-dependent Ca2 release from the ER to the cytosol and
initiates neural differentiation (Fig. 11, right panel). Ca2 then
accumulates in mitochondria through MCU resulting in the
change in the electron transport chain activity, which signifi-
cantly enhances ROS metabolism. ROS interacts with redox-
sensitive targets such as NRX. In the proliferating cells, NRX
binds DVL2 and keeps it inactive in the cytoplasm. Upon ROS
elevation, NRX releases DVL2, which becomes available to fur-
ther activate the downstream signaling cascade. As a conse-
quence, cytosolic -catenin accumulates and shuttles to the
nucleus to drive specific expression of target genes involved in
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neuronal differentiation. At the steady state, mitochondrial
Ca2 returns to baseline level and the stimulation ofmitochon-
drial ROS production is alleviated.
The metabolic switch induced by GF removal provides the
cells with a cue to change from their proliferative to the differ-
entiated state. Although Wnt/-catenin signaling induces dif-
ferentiation through regulation of target gene expression, we
show that the increased ROS metabolism is required for mod-
ulating the extent of the initial signaling response. The advan-
tage of our model system is that we can directly determine the
Wnt/-catenin signaling efficiency at the different steps of the
transduction cascade. When we inhibited the Ca2-mediated
ROS metabolism, we observed not only a delayed dissociation
of DVL2 from NRX but also a slower rate in -catenin nuclear
accumulation and lowered Wnt/-catenin target gene expres-
sion. Consequently, the neural differentiation is attenuated as
quantified by the reduced neuronal yield. Releasing the block
on ROS production led to partial recovery in the protein levels
of Wnt/-catenin pathway effectors. Already 1 h after the
exchange with drug-free medium, we showed a significant
increase in both mito-Ca2 and ROS levels with simultaneous
rise in DVL2 and NRX cytoplasmic protein levels. In addition,
we also detected elevated nuclear -catenin 2 h after the
drug depletion suggesting a partial rescue. These data indi-
cate that the response amplitudes ofWnt/-catenin pathway
effectors could be modulated by physiologic changes in ROS
metabolism.
Our data imply ROS in modifying the cellular decisions, in
our case the neural commitment of hNPCs and their differen-
tiation into neurons. Furthermore, the findings also demon-
strate that the timing of the elevated ROS production is crucial.
ROS are able to tune the intensity and the magnitude of the
Wnt/-catenin pathway responses right at the onset of neural
differentiation. In conclusion, this study shows for the first time
that endogenously induced changes in mitochondrial ROS
metabolism positively regulateWnt/-catenin signal transduc-
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tion and demonstrates that endogenous ROS act as permissive
signals inmodulating the extent of theWnt/-catenin signaling
output. Wnt/-catenin signaling is not the only developmental
pathway regulating the neural commitment of hNPCs (50).
Given the function of ROS as second messengers in many dif-
ferent aspects of cell physiology, the question whether ROS
could modulate the neural differentiation of hNPCs through
other pathways remains to be determined.
The ability of hNPCs to promptly differentiate into neurons
within 3 days upon GF removal significantly reduces not only
the time range for in vitro studies of molecular and cellular
mechanisms regulating neurogenesis but also encourages the
exploitation of these cells in studies directed toward stem cell
therapies. Our findings imply that modulating intracellular
Ca2 fluxes and/or ROS metabolism in hNPCs prior to their
neuronal fate commitment phase facilitates their neurogenesis.
This could be particularly beneficial for enhancing in vitro neu-
ronal yields and for using hNPCs as a potential neuronal source
for cell replacement and regenerative therapies in the treat-
ment of neurodegenerative diseases. Conversely, our finding
that a potent ROS scavenger NAC negatively regulates neuro-
nal differentiation prompts the re-evaluation of the therapeutic
administration of antioxidants, at leastwhen applied in the con-
text of neuronal development as suggested previously (3).
Ca2 has been shown to interact with the Wnt signaling
pathway at many different levels; its role as a secondmessenger
downstream of DVL-mediated Wnt signaling is well estab-
lished (51). Recently, it has been shown that Wnt signaling
mediates extracellular Ca2 fluxes through regulation of L-type
Ca2 channel conductance (52). In this study, we show that
Ca2-dependent events are essential for robust activation of
DVL and positively regulate Wnt/-catenin signal transduc-
tion ensuring more efficient and sustained signaling. The data
infer that ionic and metabolic cues are an integral part of the
Wnt/-catenin signaling pathway and may fine-tune the tem-
poral element of signal transduction as well as magnitudes of
responses of the pathway components.
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